Related Experiment Video
Updated: Jul 15, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Molecular profiling in breast cancer
Shannon R Morris1, Lisa A Carey
1GlaxoSmithKline, Research Triangle Park, NC, USA.
Reviews in Endocrine & Metabolic Disorders
|April 28, 2007
Abstract:
Molecular profiling has provided biological evidence for the heterogeneity of breast cancer through the identification of intrinsic subtypes like Luminal A, Luminal B, HER2+/ER- and basal-like. It has also led to the development of clinically applicable gene expression-based prognostic panels like the Mammaprint and Oncotype Dx. The increasingly sophisticated understanding allowed by this and similar technology promises future individualized therapy.
